Your browser doesn't support javascript.
loading
Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology.
Gustav, Marco; Reitsam, Nic Gabriel; Carrero, Zunamys I; Loeffler, Chiara M L; van Treeck, Marko; Yuan, Tanwei; West, Nicholas P; Quirke, Philip; Brinker, Titus J; Brenner, Hermann; Favre, Loëtitia; Märkl, Bruno; Stenzinger, Albrecht; Brobeil, Alexander; Hoffmeister, Michael; Calderaro, Julien; Pujals, Anaïs; Kather, Jakob Nikolas.
Afiliação
  • Gustav M; Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Reitsam NG; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Carrero ZI; Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Loeffler CML; Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • van Treeck M; Department of Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Yuan T; Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • West NP; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Quirke P; Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Brinker TJ; Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.
  • Brenner H; Digital Biomarkers for Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Favre L; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Märkl B; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Stenzinger A; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brobeil A; Université Paris Est Créteil, INSERM, IMRB, Créteil, France.
  • Hoffmeister M; Assistance Publique-Hôpitaux de Paris, Henri Mondor-Albert Chenevier University Hospital, Department of Pathology, Créteil, France.
  • Calderaro J; INSERM, U955, Team Oncogenèse des lymphomes et tumeurs de la Neurofibromatose 1, Créteil, France.
  • Pujals A; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Kather JN; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
NPJ Precis Oncol ; 8(1): 115, 2024 May 23.
Article em En | MEDLINE | ID: mdl-38783059
ABSTRACT
In the spectrum of colorectal tumors, microsatellite-stable (MSS) tumors with DNA polymerase ε (POLE) mutations exhibit a hypermutated profile, holding the potential to respond to immunotherapy similarly to their microsatellite-instable (MSI) counterparts. Yet, due to their rarity and the associated testing costs, systematic screening for these mutations is not commonly pursued. Notably, the histopathological phenotype resulting from POLE mutations is theorized to resemble that of MSI. This resemblance not only could facilitate their detection by a transformer-based Deep Learning (DL) system trained on MSI pathology slides, but also indicates the possibility for MSS patients with POLE mutations to access enhanced treatment options, which might otherwise be overlooked. To harness this potential, we trained a Deep Learning classifier on a large dataset with the ground truth for microsatellite status and subsequently validated its capabilities for MSI and POLE detection across three external cohorts. Our model accurately identified MSI status in both the internal and external resection cohorts using pathology images alone. Notably, with a classification threshold of 0.5, over 75% of POLE driver mutant patients in the external resection cohorts were flagged as "positive" by a DL system trained on MSI status. In a clinical setting, deploying this DL model as a preliminary screening tool could facilitate the efficient identification of clinically relevant MSI and POLE mutations in colorectal tumors, in one go.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha